E10.3392 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

Name of the Condition

• Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye

Summary

Type 1 diabetes mellitus is a chronic autoimmune condition where the pancreas produces little or no insulin. Moderate nonproliferative diabetic retinopathy is a complication affecting the retina, characterized by damage to retinal blood vessels without abnormal new blood vessel growth. This stage involves microaneurysms, retinal hemorrhages, and hard exudates. The absence of macular edema means the central retina remains free of swelling, though vision may still be impacted if the condition progresses. The specification of the left eye indicates the condition is localized to that eye.

Causes

Type 1 diabetes results from an autoimmune reaction that destroys insulin-producing cells in the pancreas. Diabetic retinopathy develops due to prolonged high blood sugar levels, which damage retinal blood vessels over time. The exact mechanisms include oxidative stress, inflammation, and vascular changes specific to ocular tissues. Moderate nonproliferative changes occur as the disease advances, while the lack of macular edema indicates the macula has not yet accumulated fluid. The left eye involvement may reflect unilateral or asymmetric disease progression.

Risk Factors

• Poor blood sugar control
• Longer duration of diabetes
• High blood pressure
• High cholesterol levels
• Smoking

Symptoms

• Blurred or distorted vision
• Floaters or spots in the visual field
• Difficulty seeing fine details
• Dark or empty areas in vision

Diagnosis

Diagnosis requires a comprehensive eye examination, including dilation to assess the retina. Additional tests may include optical coherence tomography (OCT) to evaluate retinal thickness and fluorescein angiography to detect blood vessel abnormalities. The left eye is specifically examined to confirm localization of the retinopathy.

Treatment Options

Treatment focuses on managing blood sugar levels and blood pressure to slow disease progression. Laser photocoagulation or anti-VEGF injections may be considered if retinopathy advances. Regular eye exams are essential to monitor for changes. The left eye is targeted for interventions if needed.

Prognosis and Follow-Up

With proper management, progression can be slowed, but vision loss may occur if retinopathy advances. Follow-up eye exams are recommended every 6–12 months, or more frequently if changes are detected. Early intervention improves outcomes.

Complications

• Progression to severe nonproliferative or proliferative diabetic retinopathy
• Macular edema (if fluid accumulates in the macula)
• Vision impairment or blindness if untreated
• Increased risk of other diabetic complications (e.g., nephropathy, neuropathy)

Lifestyle & Prevention

• Maintain tight blood sugar control through diet, exercise, and medication.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Protect eyes from UV light with sunglasses.
• Attend regular eye screenings to detect changes early.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or vision loss in the left eye. Regular follow-ups with an ophthalmologist are critical for monitoring retinopathy.

Tips for Medical Coders

Document the specific eye (left) and absence of macular edema to support code E10.3392. Include details on retinopathy severity (moderate nonproliferative) and any associated symptoms or interventions. Ensure documentation aligns with clinical findings to justify the code.